In support of current vaccination protocols

McIntosh, D.

Journal of the American Veterinary Medical Association 213(5): 602-603

1998


ISSN/ISBN: 0003-1488
PMID: 9731242
Document Number: 6305
Cefdinir (Omnicef - Parke-Davis), a third-generation oral cephalosporin, has been approved by the FDA for treatment of acute sinusitis, otitis media, acute exacerbations of chronic bronchitis, pharyngitis, community-acquired pneumonia and skin infections.

Document emailed within 1 workday
Secure & encrypted payments

In support of current vaccination protocols